What trends will shape the biotech industry in 2024?
2024年1月25日 · AI reshaping biotech: A key trend for 2024. AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment repurposing.
10 biotech companies to watch in 2025
2024年12月16日 · Last year, we documented nine biotechs we thought you should watch in 2024. Now, as the year has flown by and the end of 2024 is approaching, biotech companies will be setting out their plans for next year as they continue to work towards bringing their innovative therapies through the clinic and to the market in an attempt to bring new and groundbreaking medicines to patients suffering from ...
Biotech in 2024: A retrospective
2024年12月10日 · This revival was further exemplified by Upstream Bio’s October debut, where shares opened 26.5% above the initial public offering (IPO) price, valuing the company at $1.1 billion.Overall, the healthcare sector, with biotech as a significant contributor, led U.S. IPO activities in 2024, accounting for 23% of total IPO proceeds and raising $6.6 billion.
Recent biotech deals: The 2024 tracker
January 2024: AbbVie and Umoja Biopharma, both based in the United States, are partnering to develop novel in-situ CAR-T cell therapies. Umoja is eligible to receive up to $1.44 billion for option exercise fees, development, and regulatory milestones.
Recent biotech fundings: The 2024 tracker
Discover the latest in biotech funding on our dedicated page. We meticulously curate and categorize significant fundraising events to keep you informed about the cutting-edge trends and investments driving the industry forward.
Nine biotech companies to watch in 2024
2023年12月19日 · 2024 is shaping up to be an exciting year for the industry. Discover nine biotech companies to keep an eye on in 2024.
Promising cure for COPD: is a breakthrough within reach?
2024年10月9日 · FDA approves two new COPD treatments in 2024 Verona Pharma’s Ohtuvayre. In June 2024, the FDA approved the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years. The product, called Ohtuvayre (ensifentrine), was developed by Verona Pharma – a London-based company established 19 years ago to unlock the potential of ...
Seven diseases CRISPR technology could cure - Labiotech.eu
2024年4月4日 · CRISPR technology offers the promise to cure human genetic diseases with gene editing. This promise became a reality when the world’s first CRISPR therapy was approved by regulators to treat patients with sickle cell disease and beta-thalassemia last year.. American biopharma Vertex Pharmaceuticals’ CASGEVY works by turning on the BCL11A gene, which codes for fetal hemoglobin.
AlphaFold3: Revolutionizing drug discovery and development
2024年11月22日 · Building on the foundations of its hugely successful AlphaFold2, which made a fundamental breakthrough in protein structure prediction in 2020, Google DeepMind and its sister company Isomorphic Labs launched AlphaFold3 in May. After controversially withholding the code for six months, DeepMind finally – and somewhat unexpectedly – open-sourced its platform early last week, meaning academic ...
2024 biotech conferences and events - Labiotech.eu
January: 8-10 January: San Francisco, USA – Biotech Showcase 8-11 January: San Francisco, USA – 42nd Annual J.P. Morgan Healthcare Conference 8-12 January: San Francisco, USA – BIO @ JPM 9-11 January: San Francisco, USA – Redefining Early Stage Investments (RESI) 12-17 January: San Diego, USA – International Plant and Animal Genome Conference